SME-2-producing Serratia marcescens isolate from Switzerland.
Poirel
Laurent
L
Wenger
Aline
A
Bille
Jacques
J
Bernabeu
Sandrine
S
Naas
Thierry
T
Nordmann
Patrice
P
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D015780:Carbapenems / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D016868:Serratia Infections / Q000382:microbiology; D012706:Serratia marcescens / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics / Q000302:isolation & purification*; D013557:Switzerland; D018440:beta-Lactam Resistance; D001618:beta-Lactamases / Q000096:biosynthesis* / Q000235:genetics
D000900:Anti-Bacterial Agents; D015780:Carbapenems; D001618:beta-Lactamases